The abstract is read at the publisher; the summary is JClub's.
Macrophage YTHDC1/TIGAR signaling is linked to pulmonary arterial hypertension severity, and blocking YTHDC1 or TIGAR–TAK1 protects mice from hypoxia- and SU5416/hypoxia-induced disease.
- Why it matters: Inflammation contributes to pulmonary hypertension, but immune-targeted therapies have had limited success, and the role of the nuclear m6A reader YTHDC1 in macrophage-driven remodeling was unclear.
- What they did: YTHDC1 and TIGAR expression were profiled in human idiopathic or connective tissue disease-associated PAH and rodent PH specimens, then tested in myeloid-specific Ythdc1 or Tigar knockout mice and with YL-5092 or 5Z-7-oxozeaenol across hypoxia-, SU5416/hypoxia-, and monocrotaline-induced PH models.
- The result: Hypoxia increased Ythdc1, which bound and stabilized Tigar mRNA; TIGAR then interacted with Tak1 to activate NF-κB, and pharmacologic inhibition attenuated vascular inflammation and mitigated PH progression in multiple rodent models.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.